Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen.
about
A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.Opportunities for model-based precision dosing in the treatment of sickle cell anemia.Tuberculosis in children with sickle cell anaemia: a retrospective study in French tertiary care centres.Sickle cell anemia: time for personalized prescription of hydroxyurea? Focus on "Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics".Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.High body mass index in children with sickle cell disease: a retrospective single-centre audit
P2860
Q33440495-4C401C73-0081-44D0-9DDF-7BD58D0E5906Q35604335-0C92D181-C18B-4CA5-9D9E-596B8A538CAAQ36706798-8AA512BD-92EE-454C-AB56-026F91F0B951Q37439697-DA17E7D8-ECB7-4688-B78A-5B9DD0EDAB81Q38642609-E4F979D5-CD51-4A02-A4F8-B10EC45B5DB3Q38841247-B3ED7F08-0CF8-4645-93C4-D15B3D38024AQ44858960-1BB2815F-C3E8-4939-8F07-28727AD93B8DQ46922191-0AAE835D-BAD0-4ABF-8C62-5DDECBA34BB6Q58570755-4DB27217-4B80-416C-A735-9F156D038679
P2860
Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Population pharmacokinetics an ...... optimizing the dosing regimen.
@ast
Population pharmacokinetics an ...... optimizing the dosing regimen.
@en
type
label
Population pharmacokinetics an ...... optimizing the dosing regimen.
@ast
Population pharmacokinetics an ...... optimizing the dosing regimen.
@en
prefLabel
Population pharmacokinetics an ...... optimizing the dosing regimen.
@ast
Population pharmacokinetics an ...... optimizing the dosing regimen.
@en
P2093
P2860
P356
P1476
Population pharmacokinetics an ...... optimizing the dosing regimen.
@en
P2093
Anne Hulin
Anoosha Habibi
Dora Bachir
Frédéric Galactéros
Hind Sassi
Ines Paule
Kim Pd Pham
Michel Tod
Pascal Girard
P2860
P2888
P356
10.1186/1750-1172-6-30
P577
2011-05-28T00:00:00Z
P5875
P6179
1015504519